Progression of Irreversible Airflow Limitation in Asthma: Correlation with Severe Exacerbations

被引:47
|
作者
Matsunaga, Kazuto [1 ]
Hirano, Tsunahiko [1 ]
Oka, Asako [1 ]
Tanaka, Ayaka [1 ]
Kanai, Kuninobu [1 ]
Kikuchi, Takashi [1 ]
Hayata, Atsushi [1 ]
Akamatsu, Hiroaki [1 ]
Akamatsu, Keiichiro [1 ]
Koh, Yasuhiro [1 ]
Nakanishi, Masanori [1 ]
Minakata, Yoshiaki [1 ]
Yamamoto, Nobuyuki [1 ]
机构
[1] Wakayama Med Univ, Sch Med, Dept Internal Med 3, Wakayama, Japan
关键词
Airway inflammation; Airway remodeling; Airway reversibility; Bronchodilator; Lung function; LUNG-FUNCTION DECLINE; NATURAL-HISTORY; TOLL; ACTIVATION; CELLS;
D O I
10.1016/j.jaip.2015.05.005
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BACKGROUND: Severe exacerbations of asthma are periods of excess functional and pathological changes in the airways that have been proposed to induce airway remodeling. OBJECTIVE: The objective of this study was to explore whether severe exacerbations are correlated with the decline in post-bronchodilator forced expiratory volume in 1 second (FEV1) and loss of bronchodilator reversibility (BDR). METHODS: We examined the changes in FEV1 and BDR in 140 nonsmoking patients with well-controlled asthma at baseline and correlated these changes with the frequency of severe asthma exacerbations. RESULTS: A 3-year follow-up assessment was completed in 128 patients. A total of 28 (21.9%) patients experienced at least 1 severe exacerbation with a mean rate of 0.16 year(-1). The exacerbation rate was significantly correlated with an annual rate of decline in FEV1 (r = 0.49, P < .0001). Both patients with 1 exacerbation and those with 2 or more exacerbations had greater declines in FEV1 than patients with no exacerbations (no exacerbation, 13.6 mL/year; 1 exacerbation, 41.3 mL/year; 2 or more exacerbations, 58.3 mL/year; P < .01 and P < .0001, respectively). The changes in BDR from baseline to the end of the study in patients who did or did not experience an exacerbation were -1.2% and 0.1%, respectively (P < .0005). The changes in BDR were significantly correlated with the annual rates of change in FEV1 (r = 0.40, P < .0001). CONCLUSION: The occurrence of severe exacerbations of asthma is correlated with the progression of irreversible airflow limitation over time. This suggests that asthma exacerbations could have the long-term adverse consequences of structural and functional changes in the airways. (C) 2015 American Academy of Allergy, Asthma & Immunology
引用
收藏
页码:759 / +
页数:7
相关论文
共 50 条
  • [21] Associations Of Serum Periostin Level With Sinusitis Severity And Persistent Airflow Limitation In Severe Asthma
    Kimura, H.
    Konno, S.
    Nakamaru, Y.
    Makita, H.
    Taniguchi, N.
    Shimizu, K.
    Maeda, Y.
    Suzuki, M.
    Nagai, K.
    Ono, J.
    Izuhara, K.
    Nishimura, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [22] Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma
    van Veen, Ilonka H.
    ten Brinke, A.
    van der Linden, A. C.
    Rabe, K. F.
    Bel, E. H.
    [J]. RESPIRATORY MEDICINE, 2006, 100 (09) : 1534 - 1539
  • [23] Distinct Phenotypes of Smokers with Fixed Airflow Limitation Identified by Cluster Analysis of Severe Asthma
    Konno, Satoshi
    Taniguchi, Natsuko
    Makita, Hironi
    Nakamaru, Yuji
    Shimizu, Kaoruko
    Shijubo, Noriharu
    Fuke, Satoshi
    Takeyabu, Kimihiro
    Oguri, Mitsuru
    Kimura, Hirokazu
    Maeda, Yukiko
    Suzuki, Masaru
    Nagai, Katsura
    Ito, Yoichi M.
    Wenzel, Sally E.
    Nishimura, Masaharu
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (01) : 33 - 41
  • [24] Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma
    Lee, June H.
    Haselkorn, Tmirah
    Borish, Larry
    Rasouliyan, Lawrence
    Chipps, Bradley E.
    Wenzel, Sally E.
    [J]. CHEST, 2007, 132 (06) : 1882 - 1889
  • [25] Persistent airflow limitation in severe asthma: should we talk about a specific phenotype?
    Cefaloni, Francesca
    Boccabella, Cristina
    Richeldi, Luca
    Bonini, Matteo
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [26] Inflammation, airflow limitation and bronchial hyperreactivity in asthma
    Bellodi, S.
    Battistini, E.
    Girosi, D.
    Aicardi, M.
    Silvestri, M.
    Rossi, G. A.
    [J]. ADVANCES IN RESEARCH & MANAGEMENT OF ASTHMA, 2005, : 5 - 9
  • [27] Impacts of bronchiectasis in asthma patients with airflow limitation
    Nomura, Natsuko
    Matsumoto, Hisako
    Morimoto, Chie
    Oguma, Tsuyoshi
    Sato, Susumu
    Tanabe, Naoya
    Kogo, Mariko
    Tashima, Noriyuki
    Sunadome, Hironobu
    Hirai, Toyohiro
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [28] MANAGEMENT OF SEVERE EXACERBATIONS OF ASTHMA
    MANTHOUS, CA
    [J]. AMERICAN JOURNAL OF MEDICINE, 1995, 99 (03): : 298 - 308
  • [29] Exacerbations in patients with severe asthma
    Garcia De la Fuente, A.
    Albendiz Gutierrez, V. J.
    De Castro Martinez, F. J.
    Zubeldia Ortuno, J. M.
    [J]. ALLERGY, 2019, 74 : 723 - 724
  • [30] Consequences of severe asthma exacerbations
    Busse, William W.
    [J]. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 23 (01) : 44 - 50